| Staging of alzheimer's disease-related neurofibrillary changes | 1995/05/01 | English | 1,453 |
| When does age-related cognitive decline begin? | 2009/04/01 | English | 1,030 |
| Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly | 2017/01/01 | English | 768 |
| Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging | 2010/08/01 | English | 695 |
| Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment | 2006/10/01 | English | 681 |
| Blood–brain barrier: Ageing and microvascular disease – systematic review and meta-analysis | 2009/03/01 | English | 643 |
| Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease | 2003/12/01 | English | 622 |
| The impact of age, weight and gender on BDNF levels in human platelets and plasma | 2005/01/01 | English | 612 |
| Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer’s disease | 2004/01/01 | English | 609 |
| Components of postural dyscontrol in the elderly: A review | 1989/11/01 | English | 606 |
| Age-related alterations in white matter microstructure measured by diffusion tensor imaging | 2005/08/01 | English | 581 |
| Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling | 2010/02/01 | English | 536 |
| The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease | 1991/07/01 | English | 514 |
| Neuron numbers and dendritic extent in normal aging and Alzheimer's disease | 1987/11/01 | English | 491 |
| Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI | 2011/07/01 | English | 469 |
| Effects of intranasal insulin on cognition in memory-impaired older adults: Modulation by APOE genotype | 2006/03/01 | English | 458 |
| Measures of brain morphology and infarction in the framingham heart study: establishing what is normal | 2005/04/01 | English | 452 |
| Neuropathology of nondemented aging: Presumptive evidence for preclinical Alzheimer disease | 2009/07/01 | English | 442 |
| Effects of age on volumes of cortex, white matter and subcortical structures | 2005/10/01 | English | 440 |
| Common mechanisms of amyloid oligomer pathogenesis in degenerative disease | 2006/04/01 | English | 429 |
| PET imaging of amyloid deposition in patients with mild cognitive impairment | 2008/10/01 | English | 427 |
| Glia and their cytokines in progression of neurodegeneration | 2005/03/01 | English | 422 |
| Resting state fMRI in Alzheimer's disease: beyond the default mode network | 2012/08/01 | English | 399 |
| Physical activity, fitness, and gray matter volume | 2014/09/01 | English | 380 |
| Neocortical glial cell numbers in human brains | 2008/11/01 | English | 368 |
| Spatial learning and motor deficits in aged rats | 1984/03/01 | English | 365 |
| Staging of brain pathology related to sporadic Parkinson’s disease | 2003/03/01 | English | 359 |
| Insulin, insulin-degrading enzyme and amyloid-β peptide in Alzheimer's disease: review and hypothesis | 2006/02/01 | English | 354 |
| Normal neuroanatomical variation due to age: The major lobes and a parcellation of the temporal region | 2005/10/01 | English | 351 |
| Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease | 2011/05/01 | English | 350 |